Pasha 97: Everything you need to know about ivermectin

06.02.2021 - The Conversation

Pasha 97: Everything you need to know about ivermectin
Ivermectin mechanism of action 3RHW (Image by Wikimedia Commons / Public Domain)

Ivermectin has become one of the most talked about drugs in the world. A highly effective treatment for fighting parasites in animals, it was later also shown to be effective in humans. In 2015 the Nobel Prize in Physiology or Medicine was given to William Campbell and Satoshi Ōmura for discovering its use against infections caused by roundworm parasites.

Interest in the drug has spiked following laboratory evidence that it has an active ingredient that acts against the COVID-19 virus.

Distribution of the drug is highly controlled in most countries and it isn’t readily available. In South Africa it is now available for use under doctor supervision following a successful court process.

In today’s episode of Pasha, Vinny Naidoo, Dean of the University of Pretoria’s Faculty of Veterinary Science, sets out the background to the drug, what the excitement is about and why a great deal of caution is required.

Firstly, the drug has not undergone robust clinical trials to test its effectiveness in fighting COVID-19. A few trials are now under way. Secondly, effectiveness shown in a laboratory doesn’t mean that it will prove to be an effective treatment. And even if its efficacy is proved, the drug will have to be administered in a hospital by a qualified healthcare professional.

Categories: Africa, Health
Tags: , ,

Newsletter

Enter your e-mail address to subscribe to our daily news service.

Search

Training Pressenza

Documentaries Catalogue

Every Sunday

Culture and Arts Notebook

In Mobilization For Assange!

International Campaign to Abolish Nuclear Weapons

International Campaign to Abolish Nuclear Weapons

Archives

xpornplease pornjk porncuze porn800 porn600 tube300 tube100 watchfreepornsex

Except where otherwise note, content on this site is licensed under a Creative Commons Attribution 4.0 International license.